Holly A. Porter, Ph.D. - Publications

Affiliations: 
2012 Molecular Medicine University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Molecular Biology, Cell Biology, Oncology

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2013 Porter HA, Perry A, Kingsley C, Tran NL, Keegan AD. IRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumors. Cancer Letters. 338: 239-48. PMID 23562473 DOI: 10.1016/J.Canlet.2013.03.030  0.595
2012 Porter HA, Carey GB, Keegan AD. Insulin receptor substrate 1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death. Experimental Cell Research. 318: 1745-58. PMID 22652453 DOI: 10.1016/J.Yexcr.2012.04.020  0.614
2010 Porter HA, Keegan AD. Abstract 4014: Differential expression and activation of IRS1 and IRS2 in breast cancer cell lines Cancer Research. 70: 4014-4014. DOI: 10.1158/1538-7445.Am10-4014  0.603
2008 Porter HA, Keegan AD. 16 IRS1 expression enhances the sensitivity of 32D cells to chemotherapy-induced cell death Cytokine. 43: 240. DOI: 10.1016/J.Cyto.2008.07.056  0.579
Show low-probability matches.